FDA approval of exenatide, its first generic injectable GLP-1 agonist, Amneal (2024) Teva announces FDA approval and launch of generic Saxenda (liraglutide injection) first generic GLP-1 indicated for weight loss, Teva Pharmaceuticals (2025) Exenatide, DailyMed (2025) Byetta, DailyMed (2025) Liraglutide (generic Victoza), DailyMed (2025) Liraglutide (generic Saxenda), DailyMed (2025) Victoza, DailyMed (2025) Saxenda, DailyMed (2025) Compounding and the FDA: Questions and answers, U.S
The Takeaway If you are trying to lose weight or manage your blood sugar, Virta Health may be able to help
Our medically supervised weight loss program is here to help you achieve your goals with proven strategies and expert support
Hair Follicle Stimulation & Growth Support Research into GHK-CU peptides also explores their potential impact on hair growth and follicle activity
Experience the BLOOM TECH difference with our superior glutathione injections, backed by rigorous quality control and competitive pricing
Smith E, Ottosson F, Hellstrand S, et al